armidex vs aromasin question

kaysgg76

New member
hey so i just finished 4 weeks worth of anadrol 100mg ED and test cyp 400mg / week... still have 8 more weeks of test to run but i seem to have developed a little lump above my right tit. not sure if its gyno in the making? (3rd cycle, never ran an AI before or had gyno problems before) but i want this thing to go away its the size of a marble maybe? I have access to both armidex and aromasin. what do you recommend taking to try n get rid of this thing. please dont bash me for not running an AI the whole time like everyone says. you live and you learn. and i have learned this time.

also if you dont recommend either of the AIs i mentioned what do you recommend i take? thanks for the help guys
 
Both are good, I prefer aromasin now but used to prefer adex. All a mater of preference really. Adex can affect lipids negatively, that's why i switched.
 
If it is gyno, you need letro to reverse it..
Adex and aromasin are used to prevent high estro and development of gyno.. good sticky to read at top of page.
 
ok thanks. just read all the stickys RUI carries letro correct? and i can run that while on cycle until the lump goes away?
 
going to pass on the letro....according to the sticky "estrogen on cycle" seems like i want to run armidex as well as a serm. armidex to management my Estrogen levels for the rest of my cycle and the serm to take care of this stupid little lump. Can someone chime in and let me know if i read the sticky correctly. thank you
 
I found this when I was searching for my choice of AI and this is my response to this question when I see it or hear it:

"Arimidex is not a good aromatase inhibitor for men. Stick with aromasin. Arimidex is a weak inhibitor of E2(it's strength is inhibiting E1 in women. Not well suited for men). It's also a competitive inhibitor (not a suicide inhibitor) so you'll get a rebound when you come off or need a higher dose. Aromasin is a much better solution. It binds to the aromatase and kills it. So there is no rebound and stops more E2 production.

Arimidex is a competitive inhibitor so it competes for the binding site of the enzyme with testosterone and blocks it from getting converted to estrogen. It's not very good at it, but that's what it does. So the enzyme is still present in large numbers because your body overcompensates. When you stop the Arimidex the blockade is gone and the E2 levels soar. That is why suicide inhibitors like aromasin are preferred.

When it comes to this comparison its more about type of estrogen suppression as opposed to "strength". Arimidex is a VERY potent sulfatase inhibitor, which inhibits estrone. It is a moderately strong aromatase inhibitor (weak as compared to aromasin, AIFM or letrozole). This is fine for women with breast cancer who produce percentage wise very high levels of estrone (the weak estrogen), which can be converted to estradiol (the strong estrogen) via aromatase.

For men this is generally not very good, especially for men on TRT since sulfatase inhibitors have very little effect on exogenous testosterone. Actually its generally not a good thing since it nearly completely eliminates estrone, while still allowing estradiol. If you have a choice as a man, you want estrone (weak estrogen) with near total elimination of estradiol (strong). AIFM and aromasin do inhibit sulfatase, though to a lesser extent than the competitive inhibitors (dex and letro). They are both potent aromatase inhibitors and highly suppress estradiol. Since exogenous test converts to estradiol via aromatase, AIFM and aromasin are much better suited.

Lowest doses of letrozole completely suppresses glandular production of estrone(E1). while it generally takes higher end doses of exemestane (aromasin) to come close to doing this. Exemestane dose dependantly decreases estradiol and to a lesser extent estrone. Basically aromasin at low doses is mostly peripheral, which means blocking conversion of estrone, testosterone and other aromatic precursors to estradiol. Whereas because they are competitive inhibitors that have high permeability through tissue types, arimidex and letrozole have high affinity and saturation of tissues like testes and adrenals, where estrone is produced. They highly block synthesis of aromatase in those tissues at even lowest doses."

I am going to go with aromasin. But I will have one of the others on hand to experiment should aromasin be failing me, was bunk aromasin, or for experimentation. I have not had my first cycle yet so this is not my personal experience. Just something I thought sounded well thought out.
 
I found this when I was searching for my choice of AI and this is my response to this question when I see it or hear it:

"Arimidex is not a good aromatase inhibitor for men. Stick with aromasin. Arimidex is a weak inhibitor of E2(it's strength is inhibiting E1 in women. Not well suited for men). It's also a competitive inhibitor (not a suicide inhibitor) so you'll get a rebound when you come off or need a higher dose. Aromasin is a much better solution. It binds to the aromatase and kills it. So there is no rebound and stops more E2 production.

Arimidex is a competitive inhibitor so it competes for the binding site of the enzyme with testosterone and blocks it from getting converted to estrogen. It's not very good at it, but that's what it does. So the enzyme is still present in large numbers because your body overcompensates. When you stop the Arimidex the blockade is gone and the E2 levels soar. That is why suicide inhibitors like aromasin are preferred.

When it comes to this comparison its more about type of estrogen suppression as opposed to "strength". Arimidex is a VERY potent sulfatase inhibitor, which inhibits estrone. It is a moderately strong aromatase inhibitor (weak as compared to aromasin, AIFM or letrozole). This is fine for women with breast cancer who produce percentage wise very high levels of estrone (the weak estrogen), which can be converted to estradiol (the strong estrogen) via aromatase.

For men this is generally not very good, especially for men on TRT since sulfatase inhibitors have very little effect on exogenous testosterone. Actually its generally not a good thing since it nearly completely eliminates estrone, while still allowing estradiol. If you have a choice as a man, you want estrone (weak estrogen) with near total elimination of estradiol (strong). AIFM and aromasin do inhibit sulfatase, though to a lesser extent than the competitive inhibitors (dex and letro). They are both potent aromatase inhibitors and highly suppress estradiol. Since exogenous test converts to estradiol via aromatase, AIFM and aromasin are much better suited.

Lowest doses of letrozole completely suppresses glandular production of estrone(E1). while it generally takes higher end doses of exemestane (aromasin) to come close to doing this. Exemestane dose dependantly decreases estradiol and to a lesser extent estrone. Basically aromasin at low doses is mostly peripheral, which means blocking conversion of estrone, testosterone and other aromatic precursors to estradiol. Whereas because they are competitive inhibitors that have high permeability through tissue types, arimidex and letrozole have high affinity and saturation of tissues like testes and adrenals, where estrone is produced. They highly block synthesis of aromatase in those tissues at even lowest doses."

I am going to go with aromasin. But I will have one of the others on hand to experiment should aromasin be failing me, was bunk aromasin, or for experimentation. I have not had my first cycle yet so this is not my personal experience. Just something I thought sounded well thought out.

Interesting stuff, where did you find this?
 
If it is gyno, you need letro to reverse it..
Adex and aromasin are used to prevent high estro and development of gyno.. good sticky to read at top of page.

Not true. There are better options than letro. Nolva and ralox are two of them.
 
Back
Top